Avaleht › 2. tüüpi diabeet › Texas
2. tüüpi diabeet kliinilised uuringud osariigis Texas
58 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid osariigis Texas.
Linnad osariigis Texas
- San Antonio37 uuringut
- Houston31 uuringut
- Dallas19 uuringut
- Austin12 uuringut
- Mesquite8 uuringut
- Pharr8 uuringut
- The Woodlands7 uuringut
- McKinney6 uuringut
- Lewisville5 uuringut
- Sugar Land5 uuringut
- Brownsville4 uuringut
- Corpus Christi4 uuringut
- Fort Worth4 uuringut
- Cypress4 uuringut
- Round Rock4 uuringut
- Killeen4 uuringut
- Grand Prairie3 uuringut
- El Paso3 uuringut
Ametlik uuringutekst (inglise keeles)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- Houston Methodist, Houston
- Baylor Scott & White, Temple
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Baylor Scott & White, Temple
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06906627A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- ja veel 2
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Amarillo Med Spec LLP, Amarillo
- Texas Diabetes & Endocrinology, Austin
- North Texas Endocrine Center, Dallas
- ja veel 6
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- ja veel 25
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Texas Diabetes and Endocrinology - Central Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Privia Medical Group Gulf Coast, PLLC, Conroe
- ja veel 10
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07754461NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
Värbamine
Kõik vanused · Kõik sood · Uuendatud 29. sept 2026 · NCT06593327A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Hendrick Health, Abilene
- Gadolin Research, Beaumont
- CardioVoyage, LLC, Greenville
- ja veel 10
VärbamineTerved vabatahtlikud oodatud
Vanused 55 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06112418Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Endeavor Clinical Trials, San Antonio
VärbamineFaas 1
Vanused 18–65 · Kõik sood · Uuendatud 28. sept 2026 · NCT07399678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- ja veel 5
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- ja veel 5
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- The University of Texas Health Science Center at San Antonio, San Antonio
VärbamineTerved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 22. sept 2026 · NCT02969798A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Austin
- AURORA-2 Clinical Site, Brownsville
- AURORA-2 Clinical Site, DeSoto
- ja veel 10
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- M3 Wake Research - Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- SMS Clinical Research, LLC - 400 W. Kearney St, Mesquite
- ja veel 3
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 15. sept 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- ja veel 5
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- ja veel 2
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 14. sept 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- University of Texas Southwestern Medical Center, Dallas
- JCCT- Juno NW Houston, Houston
- Consano Clinical Research, LLC, Shavano Park
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Arlington Nephrology, PLLC., Arlington
- M3 Wake Research Dallas - Internal Medicine, Dallas
- Revival Research Institute, LLC, Dallas
- ja veel 10
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 11. sept 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- IMA Clinical Research, Austin
- Private Practice - Dr. Laila A. Hassan, Houston
- Radiance Clinical Research, Lampasas
- ja veel 3
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Dallas
- Research Site, Houston
- Research Site, Houston
- ja veel 6
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Austin, Austin
- Velocity Clinical Research - Dallas, Dallas
- Juno Research, LLC, Houston
- ja veel 8
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Amir Ali Hassan, MD, PA, Houston
- Consano Clinical Research, LLC, Shavano Park
VärbamineFaas 3
Vanused 10–18 · Kõik sood · Uuendatud 9. sept 2026 · NCT07282613A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
- Biopharma Informatic, LLC, Houston
- ja veel 5
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Osvaldo A Brusco MD PA, Corpus Christi
- ja veel 2
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, San Antonio
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- PharmaTex Research, Amarillo
- Pinnacle Clinical Research, Austin
- Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
- ja veel 20
VärbamineFaas 3
Vanused 45 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Dallas
- Research Site, McKinney
- Research Site, Paris
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Irving
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Texas Diabetes & Endocrinology, Austin
Värbamine
Vanused 18–80 · Kõik sood · Uuendatud 28. aug 2026 · NCT07599982Quantifying Hepatic Mitochondrial Fluxes in Humans
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 17. aug 2026 · NCT05305287A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Research Site, San Antonio
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–75 · Kõik sood · Uuendatud 12. aug 2026 · NCT07024823A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Research Institute of Dallas, Dallas
- Texas Childrens Hospital, Houston
- UT Health Houston, Houston
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 7. aug 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Houston
- Research Site, Round Rock
- Research Site, San Antonio
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. aug 2026 · NCT07664553Polypill for Prevention of Cardiomyopathy
- UT Southwestern Medical Center, Dallas
VärbamineFaas 1/2
Vanused 18–100 · Kõik sood · Uuendatud 4. aug 2026 · NCT06143566Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Baylor College of Medicine, Houston
Värbamine
Vanused 14–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Texas Diabetes and Endocrinology, Austin
- Tekton Research, McKinney
- Tekton Research, San Antonio
Värbamine
Vanused 18–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07521475SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes
- Brooke Army Medical Center, San Antonio
Värbamine
Vanused 18–70 · Kõik sood · Uuendatud 28. juuli 2026 · NCT07674628SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
- Texas Diabetes Institute/UH, San Antonio
VärbamineFaas 1
Vanused 30–75 · Kõik sood · Uuendatud 17. juuli 2026 · NCT07053306Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.